DK0855397T3 - (R)-5-brom-N-(ethyl-4-methylhexahydro-1H-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridincarboxamid, fremgangsmåde til dets fremstilling og medicinsk præparat indeholdende denne forbindelse - Google Patents

(R)-5-brom-N-(ethyl-4-methylhexahydro-1H-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridincarboxamid, fremgangsmåde til dets fremstilling og medicinsk præparat indeholdende denne forbindelse

Info

Publication number
DK0855397T3
DK0855397T3 DK96924189T DK96924189T DK0855397T3 DK 0855397 T3 DK0855397 T3 DK 0855397T3 DK 96924189 T DK96924189 T DK 96924189T DK 96924189 T DK96924189 T DK 96924189T DK 0855397 T3 DK0855397 T3 DK 0855397T3
Authority
DK
Denmark
Prior art keywords
methylhexahydro
pyridinecarboxamide
diazepin
methylamino
bromo
Prior art date
Application number
DK96924189T
Other languages
Danish (da)
English (en)
Inventor
Shiro Kato
Toshiya Morie
Hiroshi Harada
Naoyuki Yoshida
Yoshimi Hirokawa
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Application granted granted Critical
Publication of DK0855397T3 publication Critical patent/DK0855397T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DK96924189T 1995-07-28 1996-07-23 (R)-5-brom-N-(ethyl-4-methylhexahydro-1H-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridincarboxamid, fremgangsmåde til dets fremstilling og medicinsk præparat indeholdende denne forbindelse DK0855397T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP07212495 1995-07-28
PCT/JP1996/002053 WO1997005129A1 (fr) 1995-07-28 1996-07-23 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, son procede d'obtention et medicament le contenant

Publications (1)

Publication Number Publication Date
DK0855397T3 true DK0855397T3 (da) 2001-06-25

Family

ID=16623612

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96924189T DK0855397T3 (da) 1995-07-28 1996-07-23 (R)-5-brom-N-(ethyl-4-methylhexahydro-1H-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridincarboxamid, fremgangsmåde til dets fremstilling og medicinsk præparat indeholdende denne forbindelse

Country Status (25)

Country Link
US (1) US5945415A (pt)
EP (1) EP0855397B1 (pt)
KR (1) KR19990028395A (pt)
CN (1) CN1096459C (pt)
AT (1) ATE201021T1 (pt)
AU (1) AU700635B2 (pt)
BR (1) BR9609691A (pt)
CA (1) CA2228056A1 (pt)
CZ (1) CZ290442B6 (pt)
DE (1) DE69612753T2 (pt)
DK (1) DK0855397T3 (pt)
ES (1) ES2156616T3 (pt)
GR (1) GR3036089T3 (pt)
HK (1) HK1018049A1 (pt)
HU (1) HUP9901208A3 (pt)
IL (1) IL122753A (pt)
MX (1) MX9800620A (pt)
NO (1) NO312964B1 (pt)
NZ (1) NZ312799A (pt)
PL (1) PL184073B1 (pt)
PT (1) PT855397E (pt)
RU (1) RU2156248C2 (pt)
SK (1) SK282044B6 (pt)
TR (1) TR199800165T1 (pt)
WO (1) WO1997005129A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19650778C2 (de) * 1996-12-06 2001-01-04 Asta Medica Ag Verwendung von Dopaminrezeptor-Antagonisten in der palliativen Tumortherapie
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
ITBO20020198A1 (it) * 2002-04-12 2003-10-13 Univ Bologna Derivati 2 , 5 bis diammino 1 , 4 benzochenionici utili per il trattamento della malattia di alzheimer , metodo per la loro preparazione ed
EP2286817A3 (en) * 2003-01-13 2011-06-15 Edusa Pharmaceuticals, Inc Method of treating functional bowel disorders
JP2006516977A (ja) * 2003-01-13 2006-07-13 ダイノゲン ファーマシューティカルズ,インコーポレイテッド 悪心、嘔吐、レッチング、またはそれらの任意の組み合わせの治療方法
ES2290741T3 (es) * 2003-04-04 2008-02-16 Dynogen Pharmaceuticals Inc. Metodo de tratamiento de trastornos del tracto urinario inferior.
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
KR20120027111A (ko) 2009-03-31 2012-03-21 제리아 신야쿠 고교 가부시키 가이샤 1, 5-벤조디아제핀 유도체의 제조법
JP5858917B2 (ja) 2010-08-26 2016-02-10 興和株式会社 イソキノリン誘導体又はその塩の新規製造方法
ES2713686T3 (es) * 2014-02-03 2019-05-23 Mylan Laboratories Ltd Procedimiento para la preparación de intermedios de Raltegravir

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017573A (en) * 1988-07-29 1991-05-21 Dainippon Pharmaceutical Co., Ltd. Indazole-3-carboxylic acid derivatives
US5166341A (en) * 1988-07-29 1992-11-24 Dainippon Pharmaceutical Co., Ltd. 6-amino-1,4-hexahydro-1H-diazepine derivatives
JPH04210970A (ja) * 1990-01-26 1992-08-03 Dainippon Pharmaceut Co Ltd ベンズアミド誘導体及びその中間体
JPH03223265A (ja) * 1990-01-26 1991-10-02 Dainippon Pharmaceut Co Ltd 環状ジアミン誘導体
MX9206075A (es) * 1991-10-24 1993-04-01 Smithkline Beecham Plc Nuevos compuestos antagonistas del receptor 5-hidroxitriptamina y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
NO312964B1 (no) 2002-07-22
SK9398A3 (en) 1998-08-05
EP0855397B1 (en) 2001-05-09
CZ23098A3 (cs) 1998-06-17
PL184073B1 (pl) 2002-08-30
RU2156248C2 (ru) 2000-09-20
KR19990028395A (ko) 1999-04-15
WO1997005129A1 (fr) 1997-02-13
MX9800620A (es) 1998-04-30
NO980333D0 (no) 1998-01-26
CZ290442B6 (cs) 2002-07-17
NO980333L (no) 1998-03-23
EP0855397A1 (en) 1998-07-29
HUP9901208A3 (en) 2002-10-28
TR199800165T1 (xx) 1998-06-22
CN1096459C (zh) 2002-12-18
DE69612753T2 (de) 2005-07-07
DE69612753D1 (de) 2001-06-13
NZ312799A (en) 1999-04-29
CN1192213A (zh) 1998-09-02
BR9609691A (pt) 1999-03-23
ES2156616T3 (es) 2001-07-01
ATE201021T1 (de) 2001-05-15
EP0855397A4 (en) 1998-12-02
PT855397E (pt) 2001-08-30
CA2228056A1 (en) 1997-02-13
IL122753A0 (en) 1998-08-16
IL122753A (en) 2000-10-31
HUP9901208A2 (hu) 2000-04-28
PL324749A1 (en) 1998-06-08
AU700635B2 (en) 1999-01-07
AU6471796A (en) 1997-02-26
SK282044B6 (sk) 2001-10-08
GR3036089T3 (en) 2001-09-28
HK1018049A1 (en) 1999-12-10
US5945415A (en) 1999-08-31

Similar Documents

Publication Publication Date Title
NO20020968L (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
NO174202C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktivt azainden-derivater
CA2434277A1 (en) Substituted alkylamine derivatives and methods of use
DE60239939D1 (de) Neue pyrrole mit hypolipidämischer und hypocholesterischer aktivität, herstellungsverfahren, diese enthaltende pharmazeutische zusammensetzungen und deren medizinische verwendung
SE0102299D0 (sv) Compounds
MXPA04001500A (es) Compuestos que tienen un efecto sobre la glucocinasa.
SE0102300D0 (sv) Compounds
MY142551A (en) Substituted diaryl heterocycles, process for their preparation and their use as medicaments
SE9903544D0 (sv) Novel compounds
WO2004026306A3 (en) Pyrazole derivatives as transforming growth factor (tgf) inhibitors
NO20045469L (no) (S)-4-amino-5-klor-2-metoksy-N-[I-[ 1-(2-tetrahydrofurylkarbonyl)-4-piperidinylmetyl]-4-piperidinyl]benzamid, fremgangsmate for fremstilling, farmasoytiske sammensetninger inneholdende denne og intermediater derav
DK0855397T3 (da) (R)-5-brom-N-(ethyl-4-methylhexahydro-1H-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridincarboxamid, fremgangsmåde til dets fremstilling og medicinsk præparat indeholdende denne forbindelse
DE60209362D1 (de) 3-substituierte chinolin-4-carbonsäureamidderivate als nk-3- und nk-2-rezeptorantagonisten
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
ATE321550T1 (de) Medizinische zusammensetzungen zur unmittelbaren freisetzung bei oraler anwendung
NO20042881L (no) Substituerte cykloheksan-derivater